BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 1027154)

  • 1. Inhibition of biological effects of bromodeoxyuridine by deoxycytidine: correlation with decreased incorporation of bromodeoxyuridine into DNA.
    Horn D; Davidson RL
    Somatic Cell Genet; 1976 Sep; 2(5):469-81. PubMed ID: 1027154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biological and biochemical effects of bromodeoxyuridine and deoxycytidine on Syrian hamster melanoma cells.
    Kaufman ER; Davidson RL
    Somatic Cell Genet; 1978 Sep; 4(5):587-601. PubMed ID: 694730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of Friend erythroleukemic cell differentiation by bromodeoxyuridine: correlation with the amount of bromodeoxyuridine in DNA.
    Ashman CR; Davidson RL
    J Cell Physiol; 1980 Jan; 102(1):45-50. PubMed ID: 6445371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The BrdU content of DNA is decreased during reversal of inhibition of myogenesis by deoxycytidine.
    Wright WE
    Somatic Cell Genet; 1982 Sep; 8(5):547-55. PubMed ID: 7135161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bromodeoxyuridine dependence--a new mutation in mammalian cells.
    Davidson RL; Bick MD
    Proc Natl Acad Sci U S A; 1973 Jan; 70(1):138-42. PubMed ID: 4509645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversible "transformation" of bromodeoxyuridine-dependent cells by bromodeoxyuridine.
    Davidson RL; Horn D
    Proc Natl Acad Sci U S A; 1974 Sep; 71(9):3338-42. PubMed ID: 4530304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deoxycytidine reverses the suppression of pigmentation caused by 5-BrdUrd without changing the distribution of 5-BrdUrd in DNA.
    Reff ME; Davidson RL
    J Biol Chem; 1979 Aug; 254(15):6869-72. PubMed ID: 110801
    [No Abstract]   [Full Text] [Related]  

  • 8. Bromodeoxyuridine mutagenesis in mammalian cells is stimulated by purine deoxyribonucleosides.
    Kaufman ER; Davidson RL
    Somatic Cell Genet; 1979 Sep; 5(5):653-63. PubMed ID: 531735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resistance to bromodeoxyuridine mutagenesis and toxicity in mammalian cells selected for resistance to hydroxyurea.
    Davidson RL; Kaufman ER
    Somatic Cell Genet; 1979 Nov; 5(6):873-85. PubMed ID: 545727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of incorporation of bromodeoxyuridine into mammalian DNA on the migration patterns of DNA fragments subjected to pulsed-field gel electrophoresis after X irradiation or cutting with a restriction enzyme.
    Latz DL; Trinh MM; Thompson LL; Gardiner K; Zhu Y; Bodell WJ; Dewey WC
    Radiat Res; 1994 Apr; 138(1):53-60. PubMed ID: 8146300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bromodeoxyuridine- and cyclic AMP-mediated regulation of tyrosinase in Syrian hamster melanoma cells.
    Rauth S; Hoganson GE; Davidson RL
    Somat Cell Mol Genet; 1990 Nov; 16(6):583-92. PubMed ID: 2176354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The ultrastructure of melanoma cells treated with 5-bromodeoxyuridine.
    Endo H; Hu F
    J Invest Dermatol; 1974 Jun; 62(6):603-10. PubMed ID: 4209149
    [No Abstract]   [Full Text] [Related]  

  • 13. Inhibition of bromodeoxyuridine-associated sister chromatid exchanges in Bloom's syndrome cells with cycloheximide.
    Shiraishi Y; Yosida TH; Sandberg AA
    Cancer Genet Cytogenet; 1985 May; 17(1):43-54. PubMed ID: 3986750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Requirement of bromodeoxyuridine for the maintenance of "transformed" characteristics in bromodeoxyuridine dependent cells.
    Horn D; Davidson RL
    J Cell Physiol; 1975 Apr; 85(2 Pt 1):251-60. PubMed ID: 164475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of melanoma cell tyrosinase activity and tumorigenicity after incorporation of bromouracil for one or two cell divisions.
    Wrathall JR; Newcomb EW; Balint R; Zeitz L; Silagi S
    J Cell Physiol; 1975 Dec; 86 Suppl 2(3 Pt 2):581-92. PubMed ID: 811676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bromodeoxyuridine induction of deoxycytidine deaminase activity in a hamster cell line.
    Cullen BR; Bick MD
    Biochim Biophys Acta; 1978 Jan; 517(1):158-68. PubMed ID: 623754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deoxycytidine reverses the suppression of pigmentation caused by 5-BrdUrd without changing the amount of 5-BrdUrd in DNA.
    Davidson RL; Kaufman ER
    Cell; 1977 Dec; 12(4):923-9. PubMed ID: 413627
    [No Abstract]   [Full Text] [Related]  

  • 18. Suppression of tyrosinase gene expression by bromodeoxyuridine in Syrian hamster melanoma cells is not due to its incorporation into upstream or coding sequences of the tyrosinase gene.
    Rauth S; Davidson RL
    Somat Cell Mol Genet; 1993 May; 19(3):285-93. PubMed ID: 8332936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 5-Bromodeoxyuridine-tolerant melanoma cells in vitro and in vivo.
    Pasztor LM; Hu F; McNulty WP
    Yale J Biol Med; 1973 Dec; 46(5):397-410. PubMed ID: 4544338
    [No Abstract]   [Full Text] [Related]  

  • 20. Action of FdUrD and dCyd on the incorporation of BrdUrd in chinese hamster somatic cell DNA and the isolation of auxotrophic mutants.
    Labrecque R; Thirion JP
    J Cell Physiol; 1977 Feb; 90(2):321-7. PubMed ID: 138686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.